As the government moves to involve itself in more of our healthcare in the ramp-up to the implementation of Obamacare, the old ways in which it interferes with the doctor-patient relationship serve as a stark reminder of what is come. The Food and Drug Administration (FDA), the regulatory body that basically sets the tone for which drugs patients have access to, is preparing to dramatically shift the drug approval process for the United States. It appears that using the late-stage cancer drug Avastin as a test case, the FDA is using cost as a factor in the drug approval process....